[Plasma antithrombin III activity in patients with pulmonary thromboembolism].
A decreased plasma antithrombin III activity has been noted in 12 out of 20 patients. In 2 patients it was most probably congenital defect, whereas in the remaining 10 patients--acquired. The observed disorders in the activity of antithrombin III with particular reference to anticoagulant therapy have been discussed.
Vertun
B
B
Kliniki Chorób Wewnetrznych Instytutu Gruźlicy, Chorób Płuc.
Filipecki
S
S
Szczepański
M
M
Wawrzyńska
L
L
Rózycka
J
J
D000328:Adult; D000368:Aged; D000990:Antithrombin III / Q000032:analysis*; D020152:Antithrombin III Deficiency; D005260:Female; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011655:Pulmonary Embolism / Q000097:blood* / Q000188:drug therapy / Q000209:etiology; D012008:Recurrence; D013924:Thrombophlebitis / Q000097:blood / Q000150:complications*
D000990:Antithrombin III; D006493:Heparin
Aktywność antytrombiny III w osoczu u chorych z choroba zakrzepowo-zatorowa.